Cite

HARVARD Citation

    Collongues, N. et al. (2021). Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003). Brain and behavior. 11 (2), p. n/a. [Online]. 
  
Back to record